US Stock Movement: Liquidia surges on October 14th due to UTHR settlement and continued PAH sales
Bitget异动解读2026/10/14 13:41Liquidia Soars on October 14: Analysis
Keywords: UTHR settlement, PAH ongoing sales
1. On October 13, Liquidia reached a global settlement with United Therapeutics, resolving all six pending lawsuits between the parties. The net total payment is $380.7 million, to be paid in installments in 2026 and 2027.
2. On October 13, the company confirmed that YUTREPIA will continue to be used for pulmonary arterial hypertension (PAH) and maintain ongoing supply. The settlement requires the company to seek removal of the pulmonary hypertension due to interstitial lung disease (PH-ILD) indication from the product label and to cease promotion for this indication.
(Disclaimer: This content is generated by AI technology summarizing publicly available information. For reference only, not investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. inflation pressures are rising across the board; Chicago Federal Reserve President warns that the AI investment boom may lead to economic overheating.
Chicago Federal Reserve President Goolsbee stated on Wednesday that the U.S. September Consumer Price Index report indicates inflationary pressures are spreading broadly, and this trend is concerning.
Crypto prices
More
